Sanofi (NASDAQ: SNY) reported Q2 EPS of EUR2.09, EUR1.00 better than the analyst estimate of EUR1.09. Revenue for the quarter came in at EUR11.6 billion versus the consensus estimate of EUR13.02 billion.

For earnings history and earnings-related data on Sanofi (SNY) click here.